“Uncovering novel protein biomarkers in drug discovery and development: Targeting disease diagnosis and drug response monitoring“
Speakers: Christopher D. Whelan, Ph.D.Biogen Research and Early Development, Cambridge, MA.
Simina Ticau, Ph.D. Alnylam Pharmaceuticals, Cambridge, MA.
During the webinar, the speakers:
- Described how multiplex biomarker screening identified signatures to distinguish early and established Alzheimer’s disease.
- Explained how a broad screening of over 1,000 proteins identified multiple biomarkers in hATTR amyloidosis patients treated with an RNA interference therapeutic.
- Shared results comparing correlation data for key protein biomarkers using two different profiling assays.